Focus on Pradaxa
Pradaxa® is the name under which Boehringer Ingelheim Pharmaceuticals, Inc. markets a prescription anticoagulant medication generically called dabigatran.
_______________________________________________________________________________
The information you provide to us for this Free Case Evaluation will be treated as strictly confidential. You will get a reply from us no later than the next business day. Submitting a case evaluation does not obligate you to hire our law firm for your lawsuit. We handle all cases on a contingency fee basis, which means that you will make no payment for our legal services until after we have succeeded in getting legal compensation for you.
_______________________________________________________________________________
My Articles About Pradaxa
This Number Of Pradaxa Cases Is About Ten Times What It Was When The Pradaxa MDL Was Created And Assigned To Judge Herndon In August 2012
SUMMARY: In August 2012 when IN RE: PRADAXA (DABIGATRAN ETEXILATE) PRODUCTS LIABILITY LITIGATION, MDL No. 2385, was created for all Pradaxa lawsuits which had been filed in the federal court system as of that point in time, there were only 21 cases.
As of February 1, 2013, about six months later, there are 199 Pradaxa drug injury cases that have been transferred to or filed directly in the Southern District of Illinois and made part of this Pradaxa MDL litigation.
[Read article in full at original source]
Earlier Pradaxa articles by Tom Lamb on the Drug Injury Watch blog:
Drug Injury Watch: Increasing Number Of Pradaxa Lawsuits Against Boehringer Are Consolidated In Federal Court MDL
Drug Injury Watch: Pradaxa Side Effects Update Mid-2012: Deaths, Hemorrhages, Acute Renal Failure, and Stroke Events Submitted To FDA MedWatch
Drug Injury Watch: Pradaxa Bleeding Events: Four Major Factors Which Contributed To These Serious Side Effects
Drug Injury Watch: Pradaxa: Excess Number Of Severe Bleeding Events In Certain Patient Populations And Settings
Drug Injury Watch: Pradaxa: FDA Investigating Possible Higher Than Expected Incident Rate Of Serious Bleeding Side Effects
Drug Injury Watch: New Heart Drug Pradaxa May Be Sending "Early" Drug Safety Signals
_____________________________________________________________________________
News Regarding Pradaxa
FDA: Don't Use Pradaxa Blood Thinner in Patients With Artificial Heart Valve
Boehringer Sued by Hundreds Over Bleeding Tied to Pradaxa
Article Says Agency Let Risky Drugs Hit Market
Nashville heart doctors react to Pradaxa reports
EMA Recommends Patient, Prescriber Information For Pradaxa Be Updated
Pradaxa Patients Can't Stop the Bleeding
Boehringer’s Pradaxa website censured
Death magnifies Pradaxa hemorrhage concerns
Heart attack risk seen with clot drug Pradaxa
Boehringer says about 260 deaths related to Pradaxa
Boehringer says about 50 deaths related to Pradaxa
_______________________________________________________________________________
More About Pradaxa At
Our DrugInjuryLaw.com Web Site
Visit the Pradaxa Information page at our Drug Injury Law web site for up-to-the-date developments regarding personal injury and wrongful death lawsuits that involve Pradaxa.
The Law Offices of Thomas J. Lamb, P.A. is handling personal injury and wrongful death lawsuits against the drug company when any of these medical conditions developed while using Pradaxa:
- Serious Bleeding Events
- Hemorrhages
- Heart Attack or Myocardial Infarction (MI)
- Acute Coronary Syndrome (ACS)
If you or someone you know is interested in filing a claim for legal compensation, we offer a free Case Evaluation online at our Drug Injury Law web site.
In the alternative, you can call our toll-free number, (800) 426-9535, to discuss a possible Pradaxa case with attorney Tom Lamb.
______________________________________________________________________________
DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects ______________________________________________________________________________
